Medicine reading guide
Metoprolol
Metoprolol succinate extended-release tablets only; not immediate-release metoprolol tartrate or sprinkle capsules.
How it works
Metoprolol reduces the heart’s response to adrenaline-like signals. The heart usually beats more slowly and needs less oxygen. In selected people with stable heart failure, carefully adjusted long-term treatment also improves outcomes. This page covers the slow-release succinate tablet, whose schedule is different from immediate-release metoprolol.
Original content record dated 2026-09-30. Educational draft; independent clinical review pending.
About the referenced label
Selected label version 13 · SPL effective date 2026-03-16 · Retrieved 2026-10-09.
Label record supplied by Major Pharmaceuticals. This may be a repackager's record.
These dates describe the source record, not a clinical review of this explanation. The online label may change; this explanation has not been revalidated against the retained snapshot by this source check.
Uses / Symptoms
- High blood pressure and angina
- Stable heart failure: succinate extended-release
Effects
- Slows heart rate and lowers blood pressure
- Can reduce angina episodes
- Improves outcomes in eligible heart-failure patients
Side effects
- Tiredness or dizziness
- Slow pulse or low blood pressure
- Report new breathlessness, swelling or faintness
Selected uses and effects; not a complete safety list. Consult the referenced product information.
Explore the Metoprolol mechanism GIF and named chapters →
Questions about Metoprolol
What is this medicine used for?
Metoprolol succinate extended-release tablets treat hypertension and angina and reduce cardiovascular mortality and heart-failure hospitalization in appropriate heart-failure patients. This is not the same product as immediate-release tartrate. Stable chronic heart failure is distinct from acute decompensation or shock, where starting or increasing a beta blocker may be unsafe.
Why might it be prescribed for me?
A clinician may choose metoprolol succinate ER for angina, hypertension, or appropriate stable systolic heart failure. Pulse, conduction disease, bronchospasm, acute decompensation, and co-prescribed rate-slowing drugs influence the decision. It is not automatically the best treatment for uncomplicated hypertension just because it lowers blood pressure.
What improvement should I expect?
Depending on the reason for treatment, benefits may include lower blood pressure, fewer angina attacks, or better long-term outcomes in stable systolic heart failure. Pulse often slows, but a lower pulse alone does not prove that every treatment goal is met. Monitor symptoms and prescribed targets alongside heart rate.
How soon should it start working?
Heart-rate and blood-pressure effects can appear before long-term heart-failure benefits. The extended-release tablet supports beta blockade over a daily dosing interval; the label adjusts hypertension or angina doses at weekly or longer intervals and heart-failure doses more cautiously. Assess pulse, pressure, exercise symptoms, and fluid-related symptoms rather than expecting immediate cure.
How will I know whether it is helping?
Track pulse, blood pressure, dizziness, and exercise tolerance. In heart failure, also watch weight, swelling, and breathlessness during titration. People using glucose-lowering treatment need glucose monitoring because tachycardia can be masked during hypoglycemia. There is no universal pulse number at which every patient should hold a dose; use the individual order.
How does it work, in simple terms?
Metoprolol reduces the heart’s response to adrenaline-like signals. The heart usually beats more slowly and needs less oxygen. In selected people with stable heart failure, carefully adjusted long-term treatment also improves outcomes. This page covers the slow-release succinate tablet, whose schedule is different from immediate-release metoprolol.
How much is usually taken, and how often?
Adult starting doses differ substantially: the label lists 25–100 mg once daily for hypertension, 100 mg once daily for angina, and 12.5 or 25 mg once daily for heart failure. Heart-failure titration is usually at two-week intervals toward the tolerated target. Do not select a dose from another indication or formulation.
Should I take it with food?
Take the prescribed extended-release tablet once daily, preferably with or just after a meal, and follow a consistent routine. A scored tablet may be divided, but neither the whole tablet nor a half should be crushed or chewed. Confirm the bottle says succinate extended-release; immediate-release instructions are different.
What should I do if I miss a dose?
For this metoprolol succinate ER label, skip the missed dose and take only the next scheduled dose. Do not double it. If more than prescribed was taken, seek poison-control advice promptly rather than compensating by guessing the next dose. Repeated missed doses deserve a routine review because abrupt interruption can be hazardous.
What if I accidentally take too much?
Too much metoprolol can cause dangerous cardiovascular effects, including very low blood pressure or a severely slow heart rate. Contact US Poison Control at 1-800-222-1222 promptly, even if symptoms have not yet appeared. Call 911 for collapse, seizure, trouble breathing, or inability to awaken. Keep the package, amount, and timing available; do not induce vomiting.
How long might treatment continue?
Metoprolol commonly controls a continuing condition rather than curing it, so treatment may last months or years. The indication determines the review plan: hypertension is assessed through readings, while heart-failure therapy requires symptoms, pulse, and fluid-status follow-up. Feeling better alone is not a reason to stop. Ask when the next review is due.
Can I stop when I feel better?
Do not stop metoprolol abruptly. Sudden withdrawal can worsen angina and has been associated with myocardial infarction, even when unrecognized coronary disease is present. The label describes clinician-supervised reduction over one to two weeks when chronic treatment is discontinued. Severe adverse effects need urgent clinical review rather than an unsupervised taper.
What side effects are common?
Tiredness, dizziness, and a slower pulse can occur. Symptoms may also reflect excessive blood-pressure reduction or worsening heart failure and should not automatically be dismissed as adjustment. Report breathlessness, new swelling, or faintness. Metoprolol can mask a fast heartbeat during hypoglycemia, so people at risk need their usual glucose plan.
Which symptoms need urgent help?
Seek urgent help for fainting, severe breathing difficulty, chest pain, or a very slow pulse accompanied by weakness or confusion. New weight gain or increasing breathlessness in heart failure requires prompt contact with the treating team. Do not abruptly stop chronic metoprolol on your own; sudden withdrawal can worsen ischemia.
Can it interact with medicines or supplements?
Verapamil, diltiazem, digoxin, and other heart-rate-slowing medicines can increase bradycardia or conduction risk. CYP2D6 inhibitors can raise metoprolol exposure. Clonidine withdrawal needs an explicit sequence supervised by the clinician. Beta blockade may oppose beta2 bronchodilators and can mask some warning symptoms of hypoglycemia. Review all prescriptions and nonprescription products.
What about alcohol, driving, and exercise?
Metoprolol can cause dizziness, especially when treatment changes, so avoid driving or hazardous machinery until you know how you respond. Rise gradually if lightheaded. Ask about alcohol because it may worsen symptoms or blood-pressure control. Physical activity can remain beneficial, but follow the plan for your heart condition rather than using symptoms or pulse alone to set an exercise limit.
What about pregnancy, breastfeeding, or fertility?
Pregnancy and breastfeeding require an individual benefit–risk review. Maternal heart disease or hypertension may itself need treatment. Beta blockade can cause neonatal bradycardia or hypoglycemia, and the label recommends watching breastfed infants for beta-blocker effects. Do not abruptly stop established treatment because of pregnancy concerns; contact the treating clinician promptly. The label reports possible erectile dysfunction and reduced sperm motility with beta blockers; this does not establish that metoprolol causes infertility in an individual.
Will I need tests or monitoring?
Track pulse, blood pressure, dizziness, and exercise tolerance. In heart failure, also watch weight, swelling, and breathlessness during titration. People using glucose-lowering treatment need glucose monitoring because tachycardia can be masked during hypoglycemia. There is no universal pulse number at which every patient should hold a dose; use the individual order.
Is there a generic or a lower-cost option?
Metoprolol is available as a prescription generic; Toprol-XL is a familiar brand name. The actual price, insurance coverage, and local stock have not been checked here. A pharmacist can compare the exact strength and formulation, arrange refill coordination, and contact the prescriber if supply is interrupted. Do not stretch doses to make a pack last.
What if it is not helping?
Succinate ER and tartrate immediate-release deliver the same active metoprolol with different release patterns and schedules. The ER heart-failure evidence cannot simply be transferred to a once-daily immediate-release regimen. Other beta blockers differ in selectivity and outcomes evidence. Switching requires the total daily dose, indication, pulse, pressure, and formulation to be reconciled. If the treatment seems ineffective, first review reliable measurements, adherence, timing, and tolerability with the clinician. Do not switch or add another cardiovascular medicine yourself.